Clinical Trial Update: Three Year Outcomes of Combined Hydrus Microstent With iTrack Canaloplasty

View source ↗

Summary

Three-year outcomes from a clinical trial evaluating the Hydrus Microstent combined with iTrack canaloplasty for open-angle glaucoma, reporting long-term safety…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Snippet

Sponsor: University of Utah | Conditions: Glaucoma, Open Angle, MIGS | Status: ENROLLING_BY_INVITATION